Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma
Dhiraj Kumar, Mahadeo Gorain, Gautam Kundu, et al.
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Intratumor and Intertumor Heterogeneity in Melanoma
Tomasz M. Grzywa, Wiktor Paskal, Paweł Włodarski
Translational Oncology (2017) Vol. 10, Iss. 6, pp. 956-975
Open Access | Times Cited: 260
The challenge of targeting cancer stem cells to halt metastasis
Alice Agliano, Alfonso Calvo, Carol Box
Seminars in Cancer Biology (2017) Vol. 44, pp. 25-42
Open Access | Times Cited: 183
Cancer Stem Cells and Targeting Strategies
Luisa Barbato, Marco Bocchetti, Anna Di Biase, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 926-926
Open Access | Times Cited: 172
Cancer Stem Cell Plasticity – A Deadly Deal
Archana P. Thankamony, Kritika Saxena, Reshma Murali, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 139
Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
Eduardo Alvarado-Ortiz, Karen Griselda de la Cruz-López, Jared Becerril-Rico, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 124
BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
Giorgia Castellani, Mariachiara Buccarelli, Maria Beatrice Arasi, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4026-4026
Open Access | Times Cited: 56
Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma
Jingyuan Dai, Jiahui Gao, Hongchao Dong
Aging (2024)
Open Access | Times Cited: 19
Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review
Kevin Dzobo, Dimakatso Alice Senthebane, Chelene Ganz, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1896-1896
Open Access | Times Cited: 99
Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways
Xue Bai, David E. Fisher, Keith T. Flaherty
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 9, pp. 549-562
Open Access | Times Cited: 85
Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance
Saeedeh Keyvani‐Ghamsari, Khatereh Khorsandi, Azhar Rasul, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 69
Reprogramming of central carbon metabolism in cancer stem cells
Tin Lok Wong, Noélia Che, Stephanie Ma
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2017) Vol. 1863, Iss. 7, pp. 1728-1738
Closed Access | Times Cited: 76
Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents
Alessandro Rossi, Michela Roberto, Martina Panebianco, et al.
European Journal of Pharmacology (2019) Vol. 862, pp. 172621-172621
Open Access | Times Cited: 75
Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway
Dhiraj Kumar, Saikat Haldar, Mahadeo Gorain, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 64
Ablation of sensory nerves favours melanoma progression
Pedro H. D. M. Prazeres, Caroline Leonel, Walison N. Silva, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 17, pp. 9574-9589
Open Access | Times Cited: 63
Interplay between endoplasmic reticulum stress and non-coding RNAs in cancer
Tianming Zhao, Juan Du, Hui Zeng
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 57
ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas
Chuang Huang, Changhwan Yoon, Xiaohong Zhou, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 56
Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment
Nazila Fathi Maroufi, Vahid Vahedian, Saideh Hemati, et al.
Pathology - Research and Practice (2020) Vol. 216, Iss. 5, pp. 152919-152919
Closed Access | Times Cited: 55
Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
Tahereh Soltantoyeh, Behnia Akbari, Amirali Karimi, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1450-1450
Open Access | Times Cited: 55
Emerging role of interactions between tumor angiogenesis and cancer stem cells
Shuai Lv, Yufei Liu, Changheng Xie, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 468-481
Closed Access | Times Cited: 20
The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation
Amit Singh Yadav, Poonam R. Pandey, Ramesh Butti, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 56
Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol
Monica Marzagalli, Roberta M. Moretti, Elio Messi, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 50
Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications
Monica Marzagalli, M. Raimondi, Fabrizio Fontana, et al.
Seminars in Cancer Biology (2019) Vol. 59, pp. 221-235
Open Access | Times Cited: 49
Cancer stem cell analysis and targeting
Mishal Safdar, Z. M. Amin, Muneeb Ullah, et al.
Methods in cell biology (2025)
Closed Access
Regulation of Cancer Stem Cell Self-Renewal by HOXB9 Antagonizes Endoplasmic Reticulum Stress-Induced Melanoma Cell Apoptosis via the miR-765–FOXA2 Axis
Jingrong Lin, Dongmei Zhang, Yongsheng Fan, et al.
Journal of Investigative Dermatology (2018) Vol. 138, Iss. 7, pp. 1609-1619
Open Access | Times Cited: 39
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance
Naji Kharouf, Thomas W. Flanagan, Abdulhadi A. AlAmodi, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 240-240
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top